Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The European pharmaceuticals market had total revenues of $353.5 billion in 2022, representing a compound annual growth rate (CAGR) of 4.6% between 2017 and 2022.
- 0
- The European region acquired a 27.2% share of the global pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in the UK stood at 9.5% of total health spending in 2021.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Europe pharmaceuticals market by value in 2022?
- What will be the size of the Europe pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Europe pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 COMPANY PROFILES
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Pfizer Inc.
8.4. Johnson & Johnson
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 COMPANY PROFILES
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Pfizer Inc.
8.4. Johnson & Johnson
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Europe pharmaceuticals market value: $ billion, 2017-22
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: F. Hoffmann-La Roche Ltd: key facts
Table 5: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 6: F. Hoffmann-La Roche Ltd: Key Employees
Table 7: Novartis AG: key facts
Table 8: Novartis AG: Annual Financial Ratios
Table 9: Novartis AG: Key Employees
Table 10: Novartis AG: Key Employees Continued
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: Annual Financial Ratios
Table 13: Pfizer Inc.: Key Employees
Table 14: Pfizer Inc.: Key Employees Continued
Table 15: Johnson & Johnson: key facts
Table 16: Johnson & Johnson: Annual Financial Ratios
Table 17: Johnson & Johnson: Key Employees
Table 18: Johnson & Johnson: Key Employees Continued
Table 19: Europe size of population (million), 2018-22
Table 20: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Europe gdp (current prices, $ billion), 2018-22
Table 22: Europe inflation, 2018-22
Table 23: Europe consumer price index (absolute), 2018-22
Table 24: Europe exchange rate, 2018-22
Table 1: Europe pharmaceuticals market value: $ billion, 2017-22
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: F. Hoffmann-La Roche Ltd: key facts
Table 5: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 6: F. Hoffmann-La Roche Ltd: Key Employees
Table 7: Novartis AG: key facts
Table 8: Novartis AG: Annual Financial Ratios
Table 9: Novartis AG: Key Employees
Table 10: Novartis AG: Key Employees Continued
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: Annual Financial Ratios
Table 13: Pfizer Inc.: Key Employees
Table 14: Pfizer Inc.: Key Employees Continued
Table 15: Johnson & Johnson: key facts
Table 16: Johnson & Johnson: Annual Financial Ratios
Table 17: Johnson & Johnson: Key Employees
Table 18: Johnson & Johnson: Key Employees Continued
Table 19: Europe size of population (million), 2018-22
Table 20: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Europe gdp (current prices, $ billion), 2018-22
Table 22: Europe inflation, 2018-22
Table 23: Europe consumer price index (absolute), 2018-22
Table 24: Europe exchange rate, 2018-22
LIST OF FIGURES
Figure 1: Europe pharmaceuticals market value: $ billion, 2017-22
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2022
Figure 1: Europe pharmaceuticals market value: $ billion, 2017-22
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2022
